Delivery Order SPE2DB20D1100-SPE2DB25FA0P8
Award Date
1/14/25
Potential Completion Date
1/15/25
Potential Value
$4.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ondansetron ODT 4 mg tablets. The contract has a firm fixed price of $3,959.23 and a completion date of February 7, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,742.47, is for the delivery of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of January 15, 2025 and is a firm fixed-price Delivery Order. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at...
This federal contract award to Amerisourcebergen Drug Corp is for the delivery of 4,564,943,555 units of the pharmaceutical drug Ondansetron ODT 4 mg tablets. The $24,544.20 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has an ultimate completion date of June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order contract valued at $18,768.35. The contract was awarded by the Defense Logistics Agency (DLA) for the supply of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of November 7, 2024 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of Ondansetron ODT 4 MG Tablets in 30-count packages. The $16,001.94 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of May 30, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ondansetron ODT 8 mg tablets. The contract has a firm fixed price of $1,271.26 and an ultimate completion date of October 9, 2024. This is a delivery order contract, which is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $17,316.57, is for the delivery of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of June 12, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA,...
The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ondansetron ODT 4 mg tablets. The contract, valued at $13,603.15, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of March 27, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Ondansetron ODT 4 mg Tablets. The contract has a ceiling value of $10,163.92 and is a firm fixed price Delivery Order contract, with a performance period ending on June 25, 2025. The contract is not set aside for any particular business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Ondansetron ODT 4 mg Tablet 30s. The contract has a ceiling value of $9,454.77 and a completion date of February 11, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...